Microbot Medical (NASDAQ:MBOT) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?

Microbot Medical Inc. (NASDAQ:MBOT) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.98 and traded as high as $1.01. Microbot Medical shares last traded at $1.00, with a volume of 304,319 shares.

Microbot Medical Price Performance

The firm has a market cap of $18.79 million, a price-to-earnings ratio of -1.39 and a beta of 1.62. The firm’s fifty day moving average is $0.98 and its 200-day moving average is $0.98.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Microbot Medical stock. Thoroughbred Financial Services LLC purchased a new stake in Microbot Medical Inc. (NASDAQ:MBOT) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned 0.33% of Microbot Medical as of its most recent filing with the Securities & Exchange Commission. 16.30% of the stock is currently owned by institutional investors.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.